NanoEcho AB (publ) (STO:NANECH)
Sweden · Delayed Price · Currency is SEK 0.0700
-0.0011 (-1.55%)
At close: Jan 19, 2026
NanoEcho AB Company Description
NanoEcho AB (publ) engages in developing diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden.
NanoEcho AB (publ)
| Country | Sweden |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Linda Persson |
Contact Details
Address: Scheelevägen 19 Lund, 223 63 Sweden | |
| Phone | 46 7 09 24 11 21 |
| Website | nanoecho.se |
Stock Details
| Ticker Symbol | NANECH |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Linda Persson | Chief Executive Officer |
| Henrik Ljung | Chief Financial Officer |
| Magnus Santesson | Chief Technology Officer |